nach oben

Current Cardiovascular Imaging Reports

Erschienen in:

01.11.2016 | PET/MR Imaging (V Dilsizian and T Schindler, Section Editors)

Cardiovascular PET/MRI: Initial Clinical Experience

verfasst von: Kai Nassenstein, Felix Nensa

Erschienen in: Current Cardiovascular Imaging Reports | Ausgabe 11/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

The study aims to give a review of the current state of cardiovascular hybrid PET/MRI and to outline its evolution in near future.

Recent Findings

Proof of feasibility of cardiovascular hybrid PET/MRI has been provided for different cardiovascular pathologies using [¹⁸F]-fluorodeoxyglucose (FDG) as tracer; hybrid FDG PET/MRI allows in acute myocardial infarction the visualization of the area-at-risk of infarction, and initial studies show the prognostic value of PET/MRI concerning functional recovery in acute myocardial infarction. FDG PET/MRI enables the detection of inflammation in viral myocarditis; however, its clinical benefit is still unexplored. In sarcoidosis, cardiac PET/MRI provides a higher diagnostic accuracy compared to PET and MRI alone. PET/MRI shows an improved specificity concerning the differentiation between benign and malignant cardiac tumors compared to PET and MRI alone.

Summary

Cardiovascular PET/MRI is feasible, and initial studies show promising results and suggest an added value of hybrid PET/MRI over PET and MRI alone.

Nensa F, Tezgah E, Poeppel TD, Jensen CJ, Schelhorn J, Köhler J, et al. Integrated 18F-FDG-PET/MRI in the assessment of cardiac masses: a pilot study. J Nucl Med. 2014;56(2):255–60. doi:10.2967/jnumed.114.147744.CrossRefPubMed

Nensa F, Poeppel TD, Beiderwellen K, Schelhorn J, Mahabadi AA, Erbel R, et al. Hybrid PET/MR imaging of the heart: feasibility and initial results. Radiology. 2013;268(2):366–73. doi:10.1148/radiol.13130231.CrossRefPubMed

Quick HH. Integrated PET/MR. J Magn Reson Imaging. 2013;39(2):243–58. doi:10.1002/jmri.24523.CrossRefPubMed

Rischpler C, Park MJ, Fung GS, Javadi M, Tsui BM, Higuchi T. Advances in PET myocardial perfusion imaging: F-18 labeled tracers. Ann Nucl Med. 2012;26(1):1–6. doi:10.1007/s12149-011-0552-5.CrossRefPubMed

5.••

Nensa F, Poeppel T, Tezgah E, Heusch P, Nassenstein K, Mahabadi AA, et al. Integrated FDG PET/MR imaging for the assessment of myocardial salvage in reperfused acute myocardial infarction. Radiology. 2015;276(2):140564. doi:10.1148/radiol.2015140564. This study was the first to demonstrate the assessment of myocardial salvage after acute myocardial infarction using FDG-PET/MRI. The findings were later confirmed by [Ref. 12].CrossRef

6.•

Joshi NV, Vesey AT, Williams MC, Shah ASV, Calvert PA, Craighead FHM, et al. 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial. Lancet. 2013;383(9918):705–13. doi:10.1016/S0140-6736(13)61754-7. This study has found evidence for 18F-fluoride PET to identify ruptured and high-risk coronary atherosclerotic plaques. This could allow for targeted therapy and therapy monitoring.CrossRefPubMed

Lautamäki R, Tipre D, Bengel FM. Cardiac sympathetic neuronal imaging using PET. Eur J Nucl Med Mol Imaging. 2007;34 Suppl 1:S74–85. doi:10.1007/s00259-007-0442-1.CrossRefPubMed

Rischpler C, Langwieser N, Souvatzoglou M, Batrice A, van Marwick S, Snajberk J, et al. PET/MRI early after myocardial infarction: evaluation of viability with late gadolinium enhancement transmurality vs. 18F-FDG uptake. Eur Heart J Cardiovasc Imaging. 2015. doi:10.1093/ehjci/jeu317.

Nensa F, Tezgah E, Schweins K, Goebel J, Heusch P, Nassenstein K, Schlosser T, and Poeppel TD. Evaluation of a low-carbohydrate diet-based preparation protocol without fasting for cardiac PET/MR imaging. J Nucl Cardiol. 2016:1–9. doi:10.1007/s12350-016-0443-1.

10.

Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999;100(19):1992–2002.CrossRefPubMed

11.

Schlosser T, Nensa F, Mahabadi AA, Poeppel TD. Hybrid MRI/PET of the heart: a new complementary imaging technique for simultaneous acquisition of MRI and PET data. Heart. 2012;99(5):351–2. doi:10.1136/heartjnl-2012-302740.CrossRefPubMed

12.

Bulluck H, White SK, Fröhlich GM, Casson SG, O’Meara C, Newton A, et al. Quantifying the area at risk in reperfused ST-segment–elevation myocardial infarction patients using hybrid cardiac positron emission tomography–magnetic resonance imaging. Circ Cardiovasc Imaging. 2016;9(3):e003900. doi:10.1161/CIRCIMAGING.115.003900.CrossRefPubMedPubMedCentral

13.••

Rischpler C, Dirschinger RJ, Nekolla SG, Kossmann H, Nicolosi S, Hanus F, et al. Prospective evaluation of 18F-fluorodeoxyglucose uptake in postischemic myocardium by simultaneous positron emission tomography/magnetic resonance imaging as a prognostic marker of functional outcome. Circ Cardiovasc Imaging. 2016;9(4):e004316. doi:10.1161/CIRCIMAGING.115.004316. This PET/MRI study in patients with acute myocardium employing suppression of physiologic myocardial glucose uptake found the myocardial FDG uptake to correlate inversely with functional outcome. Thus, FDG uptake could be an interesting biomarker of adverse myocardial remodeling.PubMed

14.

Greulich S, Ferreira VM, Dall’Armellina E, Mahrholdt H. Myocardial inflammation—are we there yet? Curr Cardiovasc Imaging Rep. 2015;8(3):6. doi:10.1007/s12410-015-9320-6.CrossRefPubMedPubMedCentral

15.

Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, et al. Cardiovascular magnetic resonance in myocarditis: a JACC white paper. J Am Coll Cardiol. 2009;53(17):1475–87. doi:10.1016/j.jacc.2009.02.007.CrossRefPubMedPubMedCentral

16.

Radunski UK, Lund GK, Stehning C, Schnackenburg B, Bohnen S, Adam G, et al. CMR in patients with severe myocarditis: diagnostic value of quantitative tissue markers including extracellular volume imaging. JACC Cardiovasc Imaging. 2014. doi:10.1016/j.jcmg.2014.02.005.

17.

Lurz P, Luecke C, Eitel I, Föhrenbach F, Frank C, Grothoff M, et al. Comprehensive cardiac magnetic resonance imaging in patients with suspected myocarditis: the MyoRacer-trial. J Am Coll Cardiol. 2016;67(15):1800–11. doi:10.1016/j.jacc.2016.02.013.CrossRefPubMed

18.

Nensa F, Poeppel TD, Krings P, Schlosser T. Multiparametric assessment of myocarditis using simultaneous positron emission tomography/magnetic resonance imaging. Eur Heart J. 2014;35(32):2173. doi:10.1093/eurheartj/ehu086.CrossRefPubMed

19.

Olshausen GV, Hyafil F, Langwieser N, Laugwitz K-L, Schwaiger M, Ibrahim T. Detection of acute inflammatory myocarditis in Epstein Barr virus infection using hybrid 18F-fluoro-deoxyglucose–positron emission tomography/magnetic resonance imaging. Circulation. 2014;130(11):925–6. doi:10.1161/CIRCULATIONAHA.114.011000.CrossRef

20.••

Nensa F, Kloth J, Tezgah E, Poeppel TD, Heusch P, Goebel J, et al. Feasibility of FDG-PET in myocarditis: comparison to CMR using integrated PET/MRI. J Nucl Cardiol. 2016. doi:10.1007/s12350-016-0616-y. This PET/MRI study demonstrates the feasibility of FDG-PET/MRI in myocarditis and showed a good correlation between myocardial FDG uptake and MRI tissue markers of inflammation. Thus, FDG-PET/MRI in future could be used to improve non-invasive identification and monitoring of myocarditis.

21.

Greulich S, Deluigi CC, Gloekler S, Wahl A, Zürn C, Kramer U, et al. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. JACC Cardiovasc Imaging. 2013;6(4):501–11. doi:10.1016/j.jcmg.2012.10.021.CrossRefPubMed

22.

Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy CS, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11(7):1305–23. doi:10.1016/j.hrthm.2014.03.043.CrossRefPubMed

23.

White JA, Rajchl M, Butler J, Thompson RT, Prato FS, Wisenberg G. Active cardiac sarcoidosis: first clinical experience of simultaneous positron emission tomography-magnetic resonance imaging for the diagnosis of cardiac disease. Circulation. 2013;127(22):e639–41. doi:10.1161/CIRCULATIONAHA.112.001217.CrossRefPubMed

24.

Wicks E, Menezes L, Pantazis A, Mohiddin S, Porter J, Booth H, et al. 135 novel hybrid positron emission tomography-magnetic resonance (PET-MR) multi-modality inflammatory imaging has improved diagnostic accuracy for detecting cardiac sarcoidosis. Heart. 2014;100 Suppl 3:A80. doi:10.1136/heartjnl-2014-306118.135.CrossRef

25.

Kong E-J, Lee S-H, Cho I-H. Myocardial fibrosis in hypertrophic cardiomyopathy demonstrated by integrated cardiac F-18 FDG PET/MR. Nucl Med Mol Imaging. 2013;47(3):196–200. doi:10.1007/s13139-013-0201-0.CrossRefPubMedPubMedCentral

26.

Ibrahim T, Nekolla SG, Langwieser N, Rischpler C, Groha P, Laugwitz K-L, et al. Simultaneous positron emission tomography/magnetic resonance imaging identifies sustained regional abnormalities in cardiac metabolism and function in stress-induced transient midventricular ballooning syndrome. Circulation. 2012;126(21):e324–6. doi:10.1161/CIRCULATIONAHA.112.134346.CrossRefPubMed

27.

Yuan C, Mitsumori LM, Beach KW, Maravilla KR. Carotid atherosclerotic plaque: noninvasive MR characterization and identification of vulnerable lesions. Radiology. 2001;221(2):285–99. doi:10.1148/radiol.2212001612.CrossRefPubMed

28.

Oikawa M, Ota H, Takaya N, Miller Z, Hatsukami TS, Yuan C. Carotid magnetic resonance imaging. A window to study atherosclerosis and identify high-risk plaques. Circ J. 2009;73(10):1765–73.CrossRefPubMed

29.

Rudd JH, Warburton EA, Fryer TD, Jones HA, Clark JC, Antoun N, et al. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation. 2002;105(23):2708–11.CrossRefPubMed

30.

Dweck MR, Chow MW, Joshi NV, Williams MC, Jones C, Fletcher AM, et al. Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology. J Am Coll Cardiol. 2012;59(17):1539–48. doi:10.1016/j.jacc.2011.12.037.CrossRefPubMed

31.

Schäfers M, Schober O, Hermann S. Matrix-metalloproteinases as imaging targets for inflammatory activity in atherosclerotic plaques. J Nucl Med. 2010;51(5):663–6. doi:10.2967/jnumed.109.065698.CrossRefPubMed

32.

Folke Pedersen S, Vikjær Sandholt B, Høgild Keller S, Espe Hansen A, Ettrup Clemmensen A, Sillesen H, et al. 64Cu-DOTATATE PET/MRI for detection of activated macrophages in carotid atherosclerotic plaques: studies in patients undergoing endarterectomy. Arterioscler Thromb Vasc Biol. 2015. doi:10.1161/ATVBAHA.114.305067.

33.

Ripa RS, Kjær A. Imaging atherosclerosis with hybrid positron emission tomography/magnetic resonance imaging. Biomed Res Int. 2015;2015:914516. doi:10.1155/2015/914516.CrossRefPubMedPubMedCentral

34.

Pedersen SF, Ludvigsen TP, Johannesen HH, Löfgren J, Ripa RS, Hansen AE, et al. Feasibility of simultaneous PET/MR in diet-induced atherosclerotic minipig: a pilot study for translational imaging. Am J Nucl Med Mol Imaging. 2014;4(5):448–58.PubMedPubMedCentral

35.

Ripa RS, Knudsen A, Hag AM, Lebech AM, Loft A, Keller SH, et al. Feasibility of simultaneous PET/MR of the carotid artery: first clinical experience and comparison to PET/CT. Am J Nucl Med Mol Imaging. 2013;3(4):361–71.PubMedPubMedCentral

36.

Einspieler I, Thürmel K, Pyka T, Eiber M, Wolfram S, Moog P, et al. Imaging large vessel vasculitis with fully integrated PET/MRI: a pilot study. Eur J Nucl Med Mol Imaging. 2015. doi:10.1007/s00259-015-3007-8.PubMed

Titel: Cardiovascular PET/MRI: Initial Clinical Experience
verfasst von: Kai Nassenstein
Felix Nensa
Publikationsdatum: 01.11.2016
Verlag: Springer US
Erschienen in: Current Cardiovascular Imaging Reports / Ausgabe 11/2016
Print ISSN: 1941-9066
Elektronische ISSN: 1941-9074
DOI: https://doi.org/10.1007/s12410-016-9392-y

Neu im Fachgebiet Kardiologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Komplette Revaskularisation bei Infarkt: Neue Studie setzt ein Fragezeichen

24.04.2024 ACC 2024 Nachrichten

Eine FFR-gesteuerte komplette Revaskularisation war in einer Studie bei Patienten mit akutem Myokardinfarkt und koronarer Mehrgefäßerkrankung klinisch nicht wirksamer als eine alleinige Revaskularisation der Infarktarterie.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen